Search

everythinglearnresearchcommunity

for

Search:↓

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Topical JAK inhibitors may help treat some skin conditions but need more research.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

A girl initially thought to have a psychiatric disorder was later found to have a lupus-related condition, which improved with proper treatment.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

The patient was diagnosed with anorexia nervosa and severe malnutrition, requiring urgent refeeding and monitoring.

Low vitamin D levels are common in people with Alopecia Areata.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

The document concludes that diagnosing and treating Interstitial Pneumonia with Autoimmune Features (IPAF) is challenging, needs a multidisciplinary approach, and further research for better diagnostic criteria and treatments. It also emphasizes regular checks for Connective Tissue Disease symptoms in all patients with Interstitial Lung Disease.

Most women with ankylosing spondylitis tested positive for HLA-B27, suggesting it's useful for diagnosis.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

The document concludes that hair analysis is not good for assessing nutrition but can detect long-term heavy metal exposure.

Low vitamin D levels are linked to different types of hair loss.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

The machine learning model accurately predicts Systemic Lupus Erythematosus in Omani patients.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Children's hair loss can be caused by various factors and should be treated with appropriate, age-specific methods and psychological support.

The retired colonel's ankle swelling was caused by a reaction to the antibiotic levofloxacin.

Adequate steroid treatment needed to limit bone loss in PMR patients.